Cargando…

Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices

AIMS: To investigate the prevalence of electromagnetic interference (EMI) between left ventricular assist devices (LVADs) and implantable cardioverter-defibrillators (ICDs)/pacemakers (PMs). METHODS AND RESULTS: A retrospective single-centre study was conducted, including all patients undergoing Hea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yalcin, Yunus C, Kooij, Claudette, Theuns, Dominic A M J, Constantinescu, Alina A, Brugts, Jasper J, Manintveld, Olivier C, Yap, Sing-Chien, Szili-Torok, Tamas, Bogers, Ad J J C, Caliskan, Kadir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132535/ https://www.ncbi.nlm.nih.gov/pubmed/32003803 http://dx.doi.org/10.1093/europace/euaa006

Ejemplares similares

Theophylline Use to Prevent Permanent Pacing in the Contemporary Era of Heart Transplantation: The Rotterdam Experience
por: Kooij, Claudette, et al.
Publicado: (2022)

Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator
por: Yap, Sing-Chien, et al.
Publicado: (2015)

Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time
por: von Gunten, Simon, et al.
Publicado: (2016)

Survival following a concomitant aortic valve procedure during left ventricular assist device surgery: an ISHLT Mechanically Assisted Circulatory Support (IMACS) Registry analysis
por: Veenis, Jesse F., et al.
Publicado: (2020)

Three-Dimensional Analysis of the In Vivo Motion of Implantable Cardioverter Defibrillator Leads
por: Szili-Torok, Tamas, et al.
Publicado: (2021)

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs
por: Theuns, Dominic A. M. J., et al.
Publicado: (2021)

First direct human evidence of a probable implantable cardioverter-defibrillator lead-related scar serving as a substrate for ventricular tachycardia
por: Abraham, Pal, et al.
Publicado: (2015)

Aortic root thrombus after left ventricular assist device implantation and aortic valve replacement
por: Veenis, Jesse F., et al.
Publicado: (2020)

Single-Center Experience With Protocolized Treatment of Left Ventricular Assist Device Infections
por: Verkaik, Nelianne J., et al.
Publicado: (2022)

Reply to ‘Aortic valve surgery and left ventricular assist device: lights and shadows’
por: Veenis, Jesse F., et al.
Publicado: (2021)

Evaluation of recurrent ventricular tachyarrhythmias in patients who survived out-of-hospital cardiac arrest due to ventricular fibrillation: eligibility for subcutaneous implantable defibrillator therapy
por: Theuns, Dominic A. M. J., et al.
Publicado: (2018)

Evaluation of patients with a HeartMate 3 left ventricular assist device using echocardiographic particle image velocimetry
por: Schinkel, Arend F. L., et al.
Publicado: (2020)

(18)F-FDG PET/CT in the Diagnosis and Management of Continuous Flow Left Ventricular Assist Device Infections: A Case Series and Review of the Literature
por: Akin, Sakir, et al.
Publicado: (2018)

Cardiac allograft vasculopathy and donor age affecting permanent pacemaker implantation after heart transplantation
por: Roest, Stefan, et al.
Publicado: (2022)

Safety and feasibility of hemodynamic pulmonary artery pressure monitoring using the CardioMEMS device in LVAD management
por: Veenis, Jesse F., et al.
Publicado: (2021)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
por: van der Lingen, Anne‐Lotte C.J., et al.
Publicado: (2021)

Reassessment of clinical variables in cardiac resynchronization defibrillator patients at the time of first replacement: Death after replacement of CRT (DARC) score
por: Theuns, Dominic A. M. J., et al.
Publicado: (2021)

Influence of renal insufficiency pre‐heart transplantation on malignancy risk post‐heart transplantation
por: Roest, Stefan, et al.
Publicado: (2021)

Implantable cardioverter defibrillators at the end of life: future perspectives on clinical practice
por: Stoevelaar, R., et al.
Publicado: (2020)

Pocket hematoma after pacemaker or defibrillator surgery: Direct oral anticoagulants versus vitamin K antagonists
por: de Heide, John, et al.
Publicado: (2022)

127. Novel Treatment Approach for Left Ventricular Assist Device-related Infections
por: Yalcin, Yunus C, et al.
Publicado: (2019)

Transhepatic echocardiography: a novel approach for imaging in left ventricle assist device patients with difficult acoustic windows
por: Strachinaru, Mihai, et al.
Publicado: (2020)

Electromagnetic Interference in Patients with Implanted Cardioverter-Defibrillators and Implantable Loop Recorders
por: de Sousa, Marcos, et al.
Publicado: (2002)

Clinical outcomes of implantable cardioverter-defibrillator therapy in noncompaction cardiomyopathy: a systematic review and meta-analysis
por: Tukker, Martijn, et al.
Publicado: (2022)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

COVID-19-related myocarditis post-heart transplantation
por: Roest, Stefan, et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

The Impact of Electromagnetic Interference from Charging All-electric Vehicles on Implantable Cardioverter-defibrillator Performance
por: Wase, Abdul, et al.
Publicado: (2023)

Preoperative right heart hemodynamics predict postoperative acute kidney injury after heart transplantation
por: Guven, Goksel, et al.
Publicado: (2018)

Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
por: Lambiase, Pier D, et al.
Publicado: (2022)

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis
por: Klimczak-Tomaniak, Dominika, et al.
Publicado: (2019)

Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of Fallot
por: Opić, Petra, et al.
Publicado: (2012)

Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy
por: van Welsenes, G. H., et al.
Publicado: (2010)

Monitoring pulmonary pressures during long‐term continuous‐flow left ventricular assist device and fixed pulmonary hypertension: redefining alleged pathophysiological mechanisms?
por: De Bakker, Chantal C., et al.
Publicado: (2020)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018)

Incidence of end‐stage renal disease after heart transplantation and effect of its treatment on survival
por: Roest, Stefan, et al.
Publicado: (2020)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0ncmvsak6lrlmr7h2pl4bivdja